|
|
| MRD / Regn No. |
: 20230000193 |
Date |
: 30/06/2026 |
| Patient Name |
: Mohan Nagabushnam |
Age & Gender |
: 51 Yrs. / Male |
| Contact No. |
: 9159616512 |
UHID |
: |
| Ht / Wt / BMI |
: 181.3 / 101.7 / 30.94 |
BP S / BP D |
: 154 / 90 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (15/Feb/2008) | PSORIASIS (15/Feb/2023) | OBESITY (15/Feb/2008) | |
|
Subjective |
: |
NO NEW COMPLAINTS |
|
Objective |
: |
NONE,NO EVIDENCE OF PROSTATE ENLARGEMENT |
|
Analysis |
: |
TYPE 2 DM,OBESITY,PERIPHERAL NEUROPATHY,URGENCY |
|
Plan |
: |
INCREASE SEMALIX TO 0.5 MG,SEE ME IN 1 MONTH,ADD MIRABEGRON |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 194 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 265 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET GLICLAZIDE XR 30 MG
CYBLEX XR 30 MG
Medicine For GLUCOSE CONTROL |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| WATCH FOR LOW BLOOD SUGARS | |
|
2 |
INJECTION GLARGINE (INJ U300)
TOUJEO
Medicine For DIABETES |
SQ |
0-0-18 UNITS |
AFTER FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION |
SQ |
EVERY WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE | |
|
4 |
TABLET MIRABEGRON 25 MG EXTENDED RELEASE
MIRAGO 25 ER
Medicine For URGE INCONTINENCE |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 30/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
|
